SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (18962)2/20/1999 3:45:00 PM
From: VLAD  Read Replies (2) of 23519
 
Frost,

Here is an exact copy of the e-mail I sent last week:

Has Vivus made any plans to buy back shares on the open market while they
are trading at these levels?  If no, why not? Does a decision to buy back
shares have to be publically announced ASA it is agreed upon by the Vivus
board?
How much longer is Vivus going to let its shareholders hang out to dry
regarding a domestic partner?  When are we going to get the partner?  How
many more months are we going to have to listen to Wilson's bs and see some
results?
Is Vivus doing anything to market MUSE to the PCPs(eg mailings, journal
advertisements) or the target population of the 55+ group(eg magazines,
internet,etc)?
Please list all the countries FULLY LAUNCHED so far by both Astra and
Janssen vs the same list of the 22 countries which have approved MUSE.
When does Vivus expect approval for MUSE in China?
When will Alibra phase III trials be completed?
Including the $8M soon expected in milestones and the $24M in cash and cash
available securities, does Vivus have enough cash to fund current R&D, spend
a little on marketing, AND do some share repurchasing??  If so WHY DOESN'T
VIVUS DO JUST THAT??!!
Please give me a prompt reply!

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext